100 related articles for article (PubMed ID: 33488878)
1. Safety, efficacy, length of stay and patient satisfaction with outpatient management of low-risk pulmonary embolism patients - a meta-analysis.
Malik AH; Aronow WS
Arch Med Sci; 2021; 17(1):245-251. PubMed ID: 33488878
[TBL] [Abstract][Full Text] [Related]
2. Acute venous thromboembolism in the emergency department: Inpatient versus outpatient management trends from 2016 to 2019.
Grande Ratti MF; Duhart MA; Bluro IM; Sberna F; Vazquez FJ
Eur J Intern Med; 2023 Oct; 116():144-145. PubMed ID: 37453845
[No Abstract] [Full Text] [Related]
3. Safety of outpatient management of cancer-associated pulmonary embolism: a retrospective study.
Pradier M; Wang TF; Siegal DM; Le Gal G; Carrier M; Delluc A
Haematologica; 2024 May; ():. PubMed ID: 38779717
[TBL] [Abstract][Full Text] [Related]
4. Inappropriate direct oral anticoagulant prescriptions in patients with non-valvular atrial fibrillation: cross-sectional analysis of the French CACAO cohort study in primary care.
Ferrat E; Fabre J; Galletout P; Boutin E; Le Breton J; Renard V; Frappé P; Bastuji-Garin S
Br J Gen Pract; 2021; 71(703):e134-e139. PubMed ID: 33495204
[TBL] [Abstract][Full Text] [Related]
5. Real-world safety and efficacy of direct oral anticoagulants in atrial fibrillation: a systematic review and meta-analysis of 605 771 patients.
Menichelli D; Del Sole F; Di Rocco A; Farcomeni A; Vestri A; Violi F; Pignatelli P; Lip GYH; Pastori D
Eur Heart J Cardiovasc Pharmacother; 2021 Apr; 7(FI1):f11-f19. PubMed ID: 33493255
[TBL] [Abstract][Full Text] [Related]
6. American Society of Hematology 2021 guidelines for management of venous thromboembolism: prevention and treatment in patients with cancer.
Lyman GH; Carrier M; Ay C; Di Nisio M; Hicks LK; Khorana AA; Leavitt AD; Lee AYY; Macbeth F; Morgan RL; Noble S; Sexton EA; Stenehjem D; Wiercioch W; Kahale LA; Alonso-Coello P
Blood Adv; 2021 Feb; 5(4):927-974. PubMed ID: 33570602
[TBL] [Abstract][Full Text] [Related]
7. Safety of apixaban compared to warfarin in hemodialysis patients: Do antiplatelets make a difference?
Ionescu F; Cooper C; Petrescu I; George J; Mansuri S
Eur J Haematol; 2021 May; 106(5):689-696. PubMed ID: 33569825
[TBL] [Abstract][Full Text] [Related]
8. Antithrombotic Therapy in Patients With Atrial Fibrillation Treated With Oral Anticoagulation Undergoing Percutaneous Coronary Intervention: A North American Perspective: 2021 Update.
Angiolillo DJ; Bhatt DL; Cannon CP; Eikelboom JW; Gibson CM; Goodman SG; Granger CB; Holmes DR; Lopes RD; Mehran R; Moliterno DJ; Price MJ; Saw J; Tanguay JF; Faxon DP
Circulation; 2021 Feb; 143(6):583-596. PubMed ID: 33555916
[TBL] [Abstract][Full Text] [Related]
9. Impact of anticoagulant exposure misclassification on the bleeding risk of direct oral anticoagulants.
Hempenius M; Groenwold RHH; Souverein PC; de Boer A; Klungel OH; Gardarsdottir H
Br J Clin Pharmacol; 2021 Sep; 87(9):3508-3517. PubMed ID: 33543516
[TBL] [Abstract][Full Text] [Related]
10. Influence of age on the relationship between apixaban concentration and anti-factor Xa activity in older patients with non-valvular atrial fibrillation.
Kalaria SN; Zhu H; Liu Q; Florian J; Wang Y; Schwartz J
Int J Cardiol; 2021 May; 331():109-113. PubMed ID: 33529664
[TBL] [Abstract][Full Text] [Related]
11. Cancer and Embolic Stroke of Undetermined Source.
Navi BB; Kasner SE; Elkind MSV; Cushman M; Bang OY; DeAngelis LM
Stroke; 2021 Mar; 52(3):1121-1130. PubMed ID: 33504187
[TBL] [Abstract][Full Text] [Related]
12. Novel bleeding risk score for patients with atrial fibrillation on oral anticoagulants, including direct oral anticoagulants.
Adam L; Feller M; Syrogiannouli L; Del-Giovane C; Donzé J; Baumgartner C; Segna D; Floriani C; Roten L; Fischer U; Aeschbacher S; Moschovitis G; Schläpfer J; Shah D; Amman P; Kobza R; Schwenkglenks M; Kühne M; Bonati LH; Beer J; Osswald S; Conen D; Aujesky D; Rodondi N;
J Thromb Haemost; 2021 Apr; 19(4):931-940. PubMed ID: 33501722
[TBL] [Abstract][Full Text] [Related]
13. Direct Oral Anticoagulants after Ischemic Stroke: Which Patient? Which Drug? And How Early?
De Marchis GM
Hamostaseologie; 2021 Feb; 41(1):31-34. PubMed ID: 33588452
[TBL] [Abstract][Full Text] [Related]
14. Lower Risk of Dementia in Patients With Atrial Fibrillation Taking Non-Vitamin K Antagonist Oral Anticoagulants: A Nationwide Population-Based Cohort Study.
Hsu JY; Liu PP; Liu AB; Lin SM; Huang HK; Loh CH
J Am Heart Assoc; 2021 Feb; 10(5):e016437. PubMed ID: 33586465
[TBL] [Abstract][Full Text] [Related]
15. Thromboembolism in Older Adults.
Gross PL; Chan NC
Front Med (Lausanne); 2020; 7():470016. PubMed ID: 33585495
[TBL] [Abstract][Full Text] [Related]
16. Risk of Stroke vs. Intracerebral Hemorrhage in Patients with Non-Valvular Atrial Fibrillation Undergoing Percutaneous Coronary Intervention: A Systematic Review and Meta-Analysis of Randomized Controlled Trials Comparing Dual vs. Triple Antithrombotic Therapy.
Desai A; Escamilla-Ocanas C; Dilip D; Saber H; Damani R
J Stroke Cerebrovasc Dis; 2021 Apr; 30(4):105654. PubMed ID: 33578352
[TBL] [Abstract][Full Text] [Related]
17. Treatment of venous thromboembolism in cancer patients: a systematic review and meta-analysis on the efficacy and safety of different direct oral anticoagulants (DOACs).
Song X; Liu Z; Zeng R; Shao J; Liu B; Zheng Y; Liu C; Ye W
Ann Transl Med; 2021 Jan; 9(2):162. PubMed ID: 33569464
[TBL] [Abstract][Full Text] [Related]
18. Endoscopic diagnosis and management of nonvariceal upper gastrointestinal hemorrhage (NVUGIH): European Society of Gastrointestinal Endoscopy (ESGE) Guideline - Update 2021.
Gralnek IM; Stanley AJ; Morris AJ; Camus M; Lau J; Lanas A; Laursen SB; Radaelli F; Papanikolaou IS; Cúrdia Gonçalves T; Dinis-Ribeiro M; Awadie H; Braun G; de Groot N; Udd M; Sanchez-Yague A; Neeman Z; van Hooft JE
Endoscopy; 2021 Mar; 53(3):300-332. PubMed ID: 33567467
[TBL] [Abstract][Full Text] [Related]
19. Correction: Blood Pressure Control and Risk of Stroke or Systemic Embolism in Patients With Atrial Fibrillation: Results From the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) Trial.
J Am Heart Assoc; 2021 Feb; 10(4):e014653. PubMed ID: 33565319
[No Abstract] [Full Text] [Related]
20. Dynamic risk assessment to improve quality of care in patients with atrial fibrillation: the 7th AFNET/EHRA Consensus Conference.
Fabritz L; Crijns HJGM; Guasch E; Goette A; Häusler KG; Kotecha D; Lewalter T; Meyer C; Potpara TS; Rienstra M; Schnabel RB; Willems S; Breithardt G; Camm AJ; Chan A; Chua W; de Melis M; Dimopoulou C; Dobrev D; Easter C; Eckardt L; Haase D; Hatem S; Healey JS; Heijman J; Hohnloser SH; Huebner T; Ilyas BS; Isaacs A; Kutschka I; Leclercq C; Lip GYH; Marinelli EA; Merino JL; Mont L; Nabauer M; Oldgren J; Pürerfellner H; Ravens U; Savelieva I; Sinner MF; Sitch A; Smolnik R; Steffel J; Stein K; Stoll M; Svennberg E; Thomas D; Van Gelder IC; Vardar B; Wakili R; Wieloch M; Zeemering S; Ziegler PD; Heidbuchel H; Hindricks G; Schotten U; Kirchhof P
Europace; 2021 Mar; 23(3):329-344. PubMed ID: 33555020
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
